Anna Mucha-Małecka

610 total citations
46 papers, 462 citations indexed

About

Anna Mucha-Małecka is a scholar working on Oncology, Otorhinolaryngology and Cancer Research. According to data from OpenAlex, Anna Mucha-Małecka has authored 46 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 15 papers in Otorhinolaryngology and 14 papers in Cancer Research. Recurrent topics in Anna Mucha-Małecka's work include Head and Neck Cancer Studies (15 papers), Breast Cancer Treatment Studies (11 papers) and Lung Cancer Treatments and Mutations (8 papers). Anna Mucha-Małecka is often cited by papers focused on Head and Neck Cancer Studies (15 papers), Breast Cancer Treatment Studies (11 papers) and Lung Cancer Treatments and Mutations (8 papers). Anna Mucha-Małecka collaborates with scholars based in Poland, Hungary and Italy. Anna Mucha-Małecka's co-authors include Krzysztof Roszkowski, Beata Biesaga, Wojciech Jóźwicki, Agnieszka Siomek, Janusz Ryś, Krzysztof Małecki, Agnieszka Adamczyk, Anna Janecka, Joanna Niemiec and Aleksandra Ambicka and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Anna Mucha-Małecka

45 papers receiving 457 citations

Peers

Anna Mucha-Małecka
Leung Li Hong Kong
Ken Saijo Japan
Valérie Cristina Switzerland
Daniel R. Carrizosa United States
C. Sessa Switzerland
Anna Mucha-Małecka
Citations per year, relative to Anna Mucha-Małecka Anna Mucha-Małecka (= 1×) peers Vijay Patil

Countries citing papers authored by Anna Mucha-Małecka

Since Specialization
Citations

This map shows the geographic impact of Anna Mucha-Małecka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Mucha-Małecka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Mucha-Małecka more than expected).

Fields of papers citing papers by Anna Mucha-Małecka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Mucha-Małecka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Mucha-Małecka. The network helps show where Anna Mucha-Małecka may publish in the future.

Co-authorship network of co-authors of Anna Mucha-Małecka

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Mucha-Małecka. A scholar is included among the top collaborators of Anna Mucha-Małecka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Mucha-Małecka. Anna Mucha-Małecka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Püsküllüoğlu, Mirosława, Joanna Streb, Renata Pacholczak‐Madej, et al.. (2024). Treatment outcomes and prognostic factors in nonmetastatic metaplastic breast cancer patients: a multicenter retrospective cohort study. Acta Oncologica. 63. 620–635.
2.
Biesaga, Beata, Ryszard Smolarczyk, Anna Mucha-Małecka, et al.. (2022). Prognostic Significance of STING Immunoexpression in Relation to HPV16 Infection in Patients with Squamous Cell Carcinomas of Oral Cavity and Oropharynx. Biomedicines. 10(10). 2538–2538. 6 indexed citations
3.
Niemiec, Joanna, Beata Sas-Korczyńska, Mirosława Püsküllüoğlu, et al.. (2022). Adjuvant combined therapy with trastuzumab in patients with HER2-positive breast cancer and cardiac alterations: implications for optimal cardio-oncology care. Polskie Archiwum Medycyny Wewnętrznej. 132(4). 6 indexed citations
6.
Mucha-Małecka, Anna, et al.. (2021). Prognostic factors in elderly patients with T1 glottic cancer treated with radiotherapy. Scientific Reports. 11(1). 17717–17717. 4 indexed citations
7.
Biesaga, Beata, Anna Janecka, Anna Mucha-Małecka, et al.. (2021). Low frequency of HPV positivity in breast tumors among patients from south-central Poland. Infectious Agents and Cancer. 16(1). 67–67. 5 indexed citations
8.
Mucha-Małecka, Anna, et al.. (2021). Assessment of HPV16 infection in patients with laryngeal cancer. Polish Journal of Pathology. 72(1). 64–74. 1 indexed citations
9.
Mucha-Małecka, Anna, et al.. (2019). Prognostic factors in patients with T1 glottic cancer treated with radiotherapy. Strahlentherapie und Onkologie. 195(9). 792–804. 21 indexed citations
10.
Niemiec, Joanna, Agnieszka Adamczyk, Aleksandra Ambicka, et al.. (2017). Prognostic role of lymphatic vessel density and lymphovascular invasion in chemotherapy-naive and chemotherapy-treated patients with invasive breast cancer.. PubMed Central. 9(3). 1435–1447. 11 indexed citations
11.
Mucha-Małecka, Anna, Krzysztof Składowski, & Dariusz Lange. (2015). Histopathological factors influencing results of combined treatment in patients with laryngeal cancer. Polish Journal of Pathology. 3(3). 260–268. 1 indexed citations
12.
Mucha-Małecka, Anna, et al.. (2014). Postoperative irradiation in patients with pT3-4N0 laryngeal cancer: results and prognostic factors. European Archives of Oto-Rhino-Laryngology. 272(3). 673–679. 11 indexed citations
13.
Niemiec, Joanna, Agnieszka Adamczyk, Aleksandra Ambicka, et al.. (2013). Triple-negative, Basal Marker-expressing, and High-grade Breast Carcinomas are Characterized by High Lymphatic Vessel Density and the Expression of Podoplanin in Stromal Fibroblasts. Applied immunohistochemistry & molecular morphology. 22(1). 10–16. 13 indexed citations
14.
Mucha-Małecka, Anna & Krzysztof Składowski. (2013). High-dose radiotherapy alone for patients with T4-stage laryngeal cancer. Strahlentherapie und Onkologie. 189(8). 632–638. 7 indexed citations
15.
Mucha-Małecka, Anna, et al.. (2012). Long-term follow-up in adult patients with low-grade glioma (WHO II) postoperatively irradiated. Analysis of prognostic factors. Reports of Practical Oncology & Radiotherapy. 17(3). 141–145. 9 indexed citations
16.
Niemiec, Joanna, Agnieszka Adamczyk, Aleksandra Ambicka, et al.. (2012). Lymphangiogenesis assessed using three methods is related to tumour grade, breast cancer subtype and expression of basal marker. Polish Journal of Pathology. 3(3). 165–171. 6 indexed citations
17.
Blecharz, Paweł, Krzysztof Urbański, Anna Mucha-Małecka, et al.. (2011). Hematogenous metastases in patients with Stage I or II endometrial carcinoma. Strahlentherapie und Onkologie. 187(12). 806–811. 13 indexed citations
18.
Małecki, Krzysztof, Anna Mucha-Małecka, Janusz Ryś, et al.. (2010). Prognostic and predictive significance of p53, EGFr, Ki-67 in larynx preservation treatment. Reports of Practical Oncology & Radiotherapy. 15(4). 87–92. 12 indexed citations
19.
Reinfuss, Marian, Anna Mucha-Małecka, Tomasz Walasek, et al.. (2010). Palliative thoracic radiotherapy in non-small cell lung cancer. An analysis of 1250 patients. Palliation of symptoms, tolerance and toxicity. Lung Cancer. 71(3). 344–349. 42 indexed citations
20.
Mucha-Małecka, Anna, et al.. (2001). Radiotherapy of locally advanced laryngeal cancer: the Gliwice Center of Oncology experience, 1990-1996. Nowotwory Journal of Oncology. 51(1). 35–35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026